The Brazilian Health Regulatory Agency (ANVISA) approved Probiokid for use in infants and children aged 3 months to 36 months.
Lallemand Health Solutions (Toulouse, France) announced that its Probiokid probiotic ingredient has gained approval in Brazil for use in infants and children. The Brazilian Health Regulatory Agency (ANVISA) approved Probiokid for use in infants and children aged 3 months to 36 months in the Brazilian market. Numerous pediatric studies have shown that Probiokid helps support immune and gut health.
Probiokid is a combination of three Lallemand probiotic strains: L. helveticus Rosell-52, B. infantis Rosell-33, and B. bifidum Rosell-71. Probiokid already has Generally Recognized as Safe (GRAS) status in the U.S. “for non-exempt infant formula, from birth,” and is also allowed in infant foods in China.
In a press release, Solange Henoud, vice president, regulatory and compliance, Lallemand Health Solutions, stated, “Our product, supported by decades of scientific, marketing, and regulatory accomplishments, has achieved the almost impossible nowadays: getting approval in Brazil. It is the first one of this year. It’s been a while since anyone from the industry has made it this far, but with a documented product such as Probiokid, with its extensive marketing journey and various regulatory acknowledgements across the globe for infants and children, we felt confident.”